Edith A. Perez, M.D.


Edith A. Perez, M.D., a translational researcher and cancer treatment specialist, is the Chief Medical Officer of Bolt Biotherapeutics, Inc. and Professor of Medicine at Mayo Clinic. As Chief Medical Officer of Bolt Biotherapeutics, Inc., Dr. Perez is responsible for clinical strategy and development, regulatory affairs, pharmacovigilance, biostatistics, and medical affairs for the company’s diverse clinical development and early-stage immuno-oncology pipeline. Previously, Dr. Perez was Vice President and Head of the BioOncology medical unit at Genentech, Inc., overseeing all U.S. hematology and oncology medical affairs, and with her team, was involved in leading numerous trials and launching six drugs, including GAZYVA®, PERJETA®, ALECENSA® and TECENTRIQ®. Dr. Perez spent the first 20 years of her career at the Mayo Clinic where she was active in teaching, research, and patient care, with a research focus in breast cancer and translational biomarkers. She was the principal investigator of the N9831 trial, which was one of the pivotal studies that demonstrated the impact of adding trastuzumab (Herceptin®) to improve disease-free and overall survival for patients with early-stage HER-2 positive breast cancer. Dr. Perez has authored several hundred research articles in journals, books, and abstracts and has lectured at national and international meetings. She serves on the editorial boards of multiple academic journals and has also been involved in diversity leadership initiatives with ASCO and AACR and currently serves as the Chair of the Health Equity Committee for Stand Up to Cancer. Dr. Perez earned her M.D. from the University of Puerto Rico School of Medicine in San Juan and completed her residency in internal medicine at the Loma Linda University Medical Center in California. She served as a general internist in the Division of National Health Services Corps in Los Angeles and completed her Hematology/Oncology fellowship at the UC Davis School of Medicine. Dr. Perez also has pursued leadership, management, and executive development at The Wharton School of the University of Pennsylvania and Harvard Kennedy School in Boston. Dr. Perez is board certified in internal medicine, medical oncology, and hematology.